Calidi Biotherapeutics (CLDI) Q1 2024 Earnings

CLDI·Reported August 13, 2024

Diluted EPS came in at $-24.48.

Diluted EPS

$-24.48

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001493152-24-019305

Financial Snapshot

Trailing eight quarters through Q1 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q1 2024 Earnings FAQ

Common questions about Calidi Biotherapeutics's Q1 2024 earnings report.

Calidi Biotherapeutics (CLDI) reported Q1 2024 earnings on August 13, 2024.

Calidi Biotherapeutics reported diluted EPS of $-24.48 for Q1 2024.

You can read the 10-Q periodic report (0001493152-24-019305) directly on SEC EDGAR. The filing index links above go to sec.gov.